Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5166953 | 0.86 | CYP2C19 (0.44) | CYP2C19ALOX5ALDH1A1NPC1RAB9A | |
| SCHEMBL29065806 | 0.81 | ALDH1A1 (0.49) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL4364840 | 0.81 | ALDH1A1 (0.49) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL28814771 | 0.81 | ALDH1A1 (0.49) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL27987923 | 0.79 | RAB9A (0.50) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL19274402 | 0.79 | ALOX5 (0.41) | ALOX5ALDH1A1HPGDNPC1RAB9A | |
| SCHEMBL4368395 | 0.77 | HPGD (0.46) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| Carbamic Acid SCHEMBL27381962 | 0.77 | ALOX5 (0.53) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL3559567 | 0.77 | CYP2C9 (0.51) | CYP2C19ALOX5ALDH1A1HPGDNPC1 | |
| SCHEMBL11922846 | 0.77 | CYP2C9 (0.51) | CYP2C19ALOX5ALDH1A1HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100415735-C | Amino alcohol derivatives | SANKYO CO (JP) | 2008-09-03 | — | — | CN | disclosed |
| CN-1328387-C | Amino alcohol derivatives | SANKYO CO (JP) | 2007-07-25 | — | — | CN | disclosed |
| EP-1300405-B1 | AMINO ALCOHOL DERIVATIVES | SANKYO CO (JP) | 2007-04-18 | — | — | EP | disclosed |
| CN-1267429-C | Amino alcohol derivatives | SANKYO CO (JP) | 2006-08-02 | — | — | CN | disclosed |
| CN-1800175-A | Amino alcohol derivatives | SANKYO CO (JP) | 2006-07-12 | — | — | CN | disclosed |
| US-6964976-B2 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2005-11-15 | — | — | US | disclosed |
| CN-1680563-A | Amino alcohol derivatives | SANKYO CO (JP) | 2005-10-12 | — | — | CN | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| CN-1494540-A | Amino alcohol derivatives | ������������ʽ���� | 2004-05-05 | — | — | CN | disclosed |
| US-6723745-B2 | PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236297-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | CYP2C19 1228/4885ALOX5 1064/4885ALDH1A1 129/4885 |
| US-20040132784-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | CYP2C19 1228/4885ALOX5 1064/4885ALDH1A1 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.